(RTTNews) – Medtronic (MDT) has announced the enrollment of the first patient in its PELE (PEripheral Onyx Liquid Embolic) clinical trial, which will evaluate the safety and efficacy of the Onyx™ Liquid Embolic System or LES for treating arterial hemorrhage in the peripheral vasc